US equities
|
MU
$892.24
▼-4.19%
TSLA
$351.80
▼-2.94%
NVDA
$215.29
▼-0.89%
AAPL
$343.41
▲+0.41%
SPCX
$145.27
▼-2.26%
META
$710.46
▼-3.56%
SNDK
$1,322.82
▼-5.16%
MSFT
$525.30
▼-2.62%
MU
$892.24
▼-4.19%
TSLA
$351.80
▼-2.94%
NVDA
$215.29
▼-0.89%
AAPL
$343.41
▲+0.41%
SPCX
$145.27
▼-2.26%
META
$710.46
▼-3.56%
SNDK
$1,322.82
▼-5.16%
MSFT
$525.30
▼-2.62%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by scPharmaceuticals Inc.
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 19, 2025
From
scPharmaceuticals Inc.
Via
GlobeNewswire
Tickers
SCPH
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
March 06, 2025
From
scPharmaceuticals Inc.
Via
GlobeNewswire
Tickers
SCPH